Next-generation clinical phenotyping and pathophysiology of laryngeal dystonia and voice tremor
Project Number1P50DC019900-01
Contact PI/Project LeaderSIMONYAN, KRISTINA
Awardee OrganizationMASSACHUSETTS EYE AND EAR INFIRMARY
Description
Abstract Text
PROJECT SUMMARY / ABSTRACT
Laryngeal dystonia (LD) and voice tremor (VT) are hyperkinetic neurological disorders that significantly
impair voice and speech production and negatively impact the patient’s quality of life, extending beyond
speech motor alterations and often causing occupational disability and life-long social isolation. The standards
of clinical care of LD and VT are not established; that is, the differential diagnostic criteria remain vague,
leading to a high rate of misdiagnosis, whereas treatment is largely limited to temporary symptom management
with botulinum toxin injections into the affected laryngeal muscles. One of the major causes of suboptimal
clinical care of these patients is the limited understanding of their distinct clinical characteristics and neural
pathophysiology. We propose a multi-institutional, cross-disciplinary Center research program that will focus on
the delineation of unique clinical and pathophysiological features of LD and VT in order to establish the
fundamental framework for the enhanced clinical management of these disorders, including their accurate
diagnosis and disorder-specific therapies. The Center research goals will be accomplished through
collaborative clinical research studies at Massachusetts Eye and Ear Infirmary, Massachusetts General
Hospital, University of California San Francisco, and University of Utah, which will include three Center
Projects, a Scientific Core that incorporates the Clinical Research and Data Science components, and an
Administrative Core that provides an overall organizational infrastructure to the Center activities. The overall
Specific Aims of this Center will be (1) Characterization of clinical phenotypes of LD and VT; (2) Understanding
disorder-specific neural pathophysiology in LD and VT; (3) Deep brain stimulation in LD and VT, and (4)
Machine-learning platforms for differential diagnosis of LD and VT. We expect that our cross-disciplinary and
collaborative Center, encompassing the expertise in otolaryngology, speech-language pathology, neurology,
neurosurgery, brain and larynx imaging, invasive neurophysiology, and clinical neuroscience and applying
complementary multimodal methodologies across these fields, will have a significant positive impact on
developing new knowledge about the links between symptomatology and pathophysiology of LD and VT, which
will help define the new standards of enhanced clinical care of these disorders.
Public Health Relevance Statement
PROJECT NARRATIVE
The overall goals of this Center are to (1) identify integrated features of clinical, behavioral and neural
characteristics that reflect overlapping and distinct pathophysiology of laryngeal dystonia and voice tremor, and
(2) develop predictive analytics for differential diagnosis of these disorders. This research is relevant to public
health because it is expected to advance the understanding of the disorder pathophysiology and help define
new approaches for their clinical management. Thus, the proposed research is relevant to NIH’s mission that
pertains to developing fundamental knowledge that will help reduce the burdens of human disability.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAffectAnimal ModelBehavioralBotulinum ToxinsBrainBrain imagingCaliforniaCharacteristicsClinicalClinical DataClinical ManagementClinical ResearchCollaborationsCommunicationComplexDataData ScienceDeep Brain StimulationDevelopmentDiagnosisDiagnosticDifferential DiagnosisDiseaseDisease ManagementDystoniaEarEffectivenessEpidemiologyEssential TremorEyeFunctional disorderGeneral HospitalsGoalsHumanImageImpairmentInfrastructureInjectionsInvestigationKnowledgeLaryngeal muscle structureLarynxLifeLinkMachine LearningMassachusettsMeasuresMethodologyMethodsMissionMonitorMotorMovement DisordersNeurologyNeurosciencesOccupationalOperative Surgical ProceduresOtolaryngologyOutcomePatient CarePatientsPhenotypePredictive AnalyticsProductionPublic HealthQuality of lifeRecommendationRecordsResearchResearch PersonnelSan FranciscoSiteSocial isolationSpasmSpastic DysphoniasSpeechSpeech AcousticsSpeech-Language PathologyStratificationSymptomsTestingTranslatingTreatment EfficacyTremorUnited States National Institutes of HealthUniversitiesUtahVoiceaccurate diagnosisbaseclinical careclinical decision-makingclinical examinationclinical phenotypedisabilityearly detection biomarkerseffective therapyimprovedmultimodalitynervous system disorderneural circuitneuroimagingneurophysiologyneuroregulationneurosurgerynext generationnovel strategiesphenomenological modelsprogramsrelating to nervous systemrepositoryresearch studysymptom managementsymptomatologytooltreatment planning
National Institute on Deafness and Other Communication Disorders
CFDA Code
173
DUNS Number
073825945
UEI
NA7AKMLK2BM1
Project Start Date
15-September-2021
Project End Date
31-August-2026
Budget Start Date
15-September-2021
Budget End Date
31-August-2022
Project Funding Information for 2021
Total Funding
$2,478,460
Direct Costs
$1,940,413
Indirect Costs
$538,047
Year
Funding IC
FY Total Cost by IC
2021
National Institute on Deafness and Other Communication Disorders
$2,478,460
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1P50DC019900-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P50DC019900-01
Patents
No Patents information available for 1P50DC019900-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P50DC019900-01
Clinical Studies
No Clinical Studies information available for 1P50DC019900-01
News and More
Related News Releases
No news release information available for 1P50DC019900-01
History
No Historical information available for 1P50DC019900-01
Similar Projects
No Similar Projects information available for 1P50DC019900-01